News Detail
![](pdf/zantac150020724090544.jpg)
London, 2 July 2024: A Delaware judge rebuffed a request by GSK and other drugmakers to appeal a ruling allowing more than 70,000 lawsuits claiming that the heartburn drug Zantac causes cancer to go forward.
The ruling by Judge Vivian Medinilla of the Delaware Superior......
View Details
Source : Reuters
Zantac cancer lawsuits
Health news
judge Vivian Medinilla
GSK
Pfizer
drugmakers
Sanofi
Boehringer Ingelheim
appeal
Related News
- Telangana DCA busted a unit manufacturing spurious 'Eptoin' and 'Vasograin Tab' (04-07-2024)
- Ministry of Ayush notifies omission of Rule 170 that regulate ads of ASU drugs (04-07-2024)
- USFDA issued warning letter to Sun Pharma for manufacturing issues at Dadra facility (04-07-2024)
- Punjab-based company booked for producing ‘substandard’ antibiotic (04-07-2024)
- 60 small drug makers join govt scheme to modernise pharma manufacturing units (04-07-2024)
- Centre eases rules for global sourcing of 354 medical devices (03-07-2024)
- Lilly received marketing authorization for Tirzepatide in India (03-07-2024)
- Delhi HC quashes PCI's decision on annual approval for pharmacy courses (03-07-2024)
- DoP to launch scheme for common facilities in state-supported medical device parks: DoP Secretary (03-07-2024)
- Multiple Pharmaceutical Firms Under Scrutiny For Illicit Drug Manufacturing & Distribution: ED Probe (03-07-2024)